These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto T; Sakamoto M; Mitsumori M; Shibuya K; Araki N; Yano S; Hiraoka M Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1427-31. PubMed ID: 16169670 [TBL] [Abstract][Full Text] [Related]
9. Stereotactic Body Radiotherapy in Patients with Lung Oligometastases from Colorectal Cancer. Pasqualetti F; Montrone S; Vivaldi C; Zani M; Fedele D; Fornaro L; Pasqualetti G; Salvatore L; Manfredi B; Laliscia C; Coraggio G; Gonnelli A; Loupakis F; Masi G; Sainato A; Monzani F; Falcone A; Paiar F Anticancer Res; 2017 Jan; 37(1):315-319. PubMed ID: 28011508 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases. Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Chaudhuri AA; Tang C; Binkley MS; Jin M; Wynne JF; von Eyben R; Hara WY; Trakul N; Loo BW; Diehn M Lung Cancer; 2015 Jul; 89(1):50-6. PubMed ID: 25997421 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer. Jung J; Song SY; Kim JH; Yu CS; Kim JC; Kim TW; Jeong SY; Kim SS; Choi EK Radiat Oncol; 2015 Nov; 10():238. PubMed ID: 26588896 [TBL] [Abstract][Full Text] [Related]
14. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. Binkley MS; Trakul N; Jacobs LR; von Eyben R; Le QT; Maxim PG; Loo BW; Shultz DB; Diehn M Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1044-1052. PubMed ID: 26025776 [TBL] [Abstract][Full Text] [Related]
15. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up. Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627 [TBL] [Abstract][Full Text] [Related]
16. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346 [TBL] [Abstract][Full Text] [Related]
17. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome. Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556 [TBL] [Abstract][Full Text] [Related]
18. Study of 201 non-small cell lung cancer patients given stereotactic ablative radiation therapy shows local control dependence on dose calculation algorithm. Latifi K; Oliver J; Baker R; Dilling TJ; Stevens CW; Kim J; Yue B; Demarco M; Zhang GG; Moros EG; Feygelman V Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1108-13. PubMed ID: 24529716 [TBL] [Abstract][Full Text] [Related]
19. Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study. He X; Zhang P; Li Z; Bi F; Xu F; Wang X; Shen Y; Li Q; Qiu M Medicine (Baltimore); 2018 Oct; 97(40):e12601. PubMed ID: 30290630 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]